As the PD1 (rs36084323) is an intronic mutation in the promoter region, it might affect the binding affinity of transcription factors, thus disrupting the activation of the gene and influencing the progression of malignant diseases such as cancer [29]. This evidence concerns the gene PDCD1 and cancer.